Phase I and Pharmacokinetic Study of Tegafur-Uracil/Leucovorin Combined With 5-Fluorouracil/Leucovorin and Irinotecan in Patients With Advanced Colorectal Cancer

MLA

Katsuhiko Okumura, et al. “Phase I and Pharmacokinetic Study of Tegafur-Uracil/Leucovorin Combined With 5-Fluorouracil/Leucovorin and Irinotecan in Patients With Advanced Colorectal Cancer.” American Journal of Clinical Oncology, vol. 32, Feb. 2009, pp. 56–60. EBSCOhost, https://doi.org/10.1097/coc.0b013e31817c6a68.

APA

Katsuhiko Okumura, Takeshi Azuma, Tatsuya Okuno, Hogara Nishisaki, Naoko Chayahara, Toshiyuki Sakaeda, Takao Tamura, Masato Kasuga, Yuko Kadowaki, Motohiro Yamamori, Midori Hirai, Masahiro Tsuda, Tetsuo Maeda, Yoshifumi Inoue, & Ikuya Miki. (2009). Phase I and Pharmacokinetic Study of Tegafur-Uracil/Leucovorin Combined With 5-Fluorouracil/Leucovorin and Irinotecan in Patients With Advanced Colorectal Cancer. American Journal of Clinical Oncology, 32, 56–60. https://doi.org/10.1097/coc.0b013e31817c6a68

Chicago

Katsuhiko Okumura, Takeshi Azuma, Tatsuya Okuno, Hogara Nishisaki, Naoko Chayahara, Toshiyuki Sakaeda, Takao Tamura, et al. 2009. “Phase I and Pharmacokinetic Study of Tegafur-Uracil/Leucovorin Combined With 5-Fluorouracil/Leucovorin and Irinotecan in Patients With Advanced Colorectal Cancer.” American Journal of Clinical Oncology 32 (February): 56–60. doi:10.1097/coc.0b013e31817c6a68.